There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Healthpeak Properties (DOC – Research Report) and CoStar Group (CSGP – Research Report) with bullish sentiments.
Healthpeak Properties (DOC)
RBC Capital analyst Michael Carroll maintained a Buy rating on Healthpeak Properties yesterday and set a price target of $22.00. The company’s shares closed last Tuesday at $19.34.
According to TipRanks.com, Carroll is a 4-star analyst with an average return of
Healthpeak Properties has an analyst consensus of Moderate Buy, with a price target consensus of $20.82, implying a 9.3% upside from current levels. In a report issued on April 1, Bank of America Securities also upgraded the stock to Buy with a $25.00 price target.
See the top stocks recommended by analysts >>
CoStar Group (CSGP)
In a report released yesterday, Ashish Sabadra from RBC Capital maintained a Buy rating on CoStar Group, with a price target of $109.00. The company’s shares closed last Tuesday at $95.69, close to its 52-week high of $100.38.
According to TipRanks.com, Sabadra is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for CoStar Group with a $98.75 average price target, which is a 4.0% upside from current levels. In a report released yesterday, KBW also maintained a Buy rating on the stock with a $109.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on DOC:
- Crocs initiated, Bill downgraded: Wall Street’s top analyst calls
- Healthpeak Properties upgraded to Buy from Underperform at BofA
- Healthpeak Properties price target raised to $26 from $22 at Baird
- Healthpeak Properties resumed with an Equal Weight at Wells Fargo
- Healthpeak Properties resumed with an Outperform at RBC Capital
